Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Congress Hub
Toolkit
Paediatric Growth Calculator
DVT Risk Calculator
Collaborate
About
EQOH
Careers
Contact Us
EMJ Media Pack
AMJ Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Pharma Partners
EMJ Interactive
EMJ GOLD
search
Subscribe
FREE
This site is intended for healthcare professionals
You must accept all conditions before being able to view the post
Continue
EUR
USA
EUR
USA
Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Congress Hub
Toolkit
Paediatric Growth Calculator
DVT Risk Calculator
Collaborate
About
EQOH
Careers
Contact Us
EMJ Media Pack
AMJ Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Pharma Partners
EMJ Interactive
EMJ GOLD
Subscribe
FREE
Pharma News, Views & Analysis
Filter
News
Articles
Podcasts
Infographics
Advertise With Us
Advertise With Us
New VPAG deadline extension announced by ABPI
The UK government has extended the deadline for organisations to submit notice to leave the scheme by two weeks.
Read more
New VPAG deadline extension announced by ABPI
The UK government has extended the deadline for organisations to submit notice to leave the scheme by two weeks.
Novartis bets $12bn on RNA with Avidity buy
Novartis to acquire Avidity Biosciences for $12bn, boosting its RNA neuromuscular pipeline as pharma M&A heats up in the RNA space.
Google quantum chip could speed up drug discovery
Google’s Quantum Echoes breakthrough could revolutionise drug discovery, offering faster, more precise ways to design new medicines.
Cell-based flu vaccines could offer 20% more protection
CSL Seqirus real-world study finds cell-based flu vaccines offer stronger protection than egg-based options in 2023/24 season.
Lundbeck and Contera partner on RNA-targeted drug discovery
Lundbeck is partnering with Contera Pharma to accelerate RNA-targeted drug discovery for serious neurological conditions.
ViiV's bi-monthly HIV injection approved by NICE
Injectable HIV PrEP marks a breakthrough in prevention, providing a new option for patients in England unable to take daily pills.
Roche breaks world record for human genome sequencing
Roche has set a new Guinness World Record for the fastest DNA sequencing of a human genome, marking a major milestone in genomic innovation.
AstraZeneca to offer up to 80% off US drug prices
AstraZeneca joins Trump’s drug pricing plan, pledging $50bn US investment and discounts of up to 80% to cut prescription medicine costs.
Loading posts...
1
2
3
…
36
Next »
We’ve noticed you’re accessing
from
North/South America.
View
View